185 related articles for article (PubMed ID: 2440378)
1. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
[TBL] [Abstract][Full Text] [Related]
3. The adrenoleukodystrophy-adrenomyeloneuropathy complex: is it treatable?
Kolodny EH
Ann Neurol; 1987 Mar; 21(3):230-1. PubMed ID: 2440377
[No Abstract] [Full Text] [Related]
4. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
[TBL] [Abstract][Full Text] [Related]
5. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
[TBL] [Abstract][Full Text] [Related]
6. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
Moser HW; Moser AE; Singh I; O'Neill BP
Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
[TBL] [Abstract][Full Text] [Related]
7. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
8. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
Stradomska TJ; Tylki-Szymańska A
Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
[TBL] [Abstract][Full Text] [Related]
9. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.
Van Duyn MA; Moser AE; Brown FR; Sacktor N; Liu A; Moser HW
Am J Clin Nutr; 1984 Aug; 40(2):277-84. PubMed ID: 6465061
[TBL] [Abstract][Full Text] [Related]
10. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
[TBL] [Abstract][Full Text] [Related]
11. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
[TBL] [Abstract][Full Text] [Related]
12. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
13. Dietary management of X-linked adrenoleukodystrophy.
Moser HW; Borel J
Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
[TBL] [Abstract][Full Text] [Related]
14. Dietary treatment of adrenoleukodystrophy.
Suzuki S; Kobayashi T; Goto I; Kuroiwa Y
Neurology; 1986 Jan; 36(1):104-6. PubMed ID: 3941763
[TBL] [Abstract][Full Text] [Related]
15. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment.
Watkins PA; Naidu S; Moser HW
J Inherit Metab Dis; 1987; 10 Suppl 1():46-53. PubMed ID: 3119941
[TBL] [Abstract][Full Text] [Related]
16. [Symptomatic adrenoleukodystrophy heterozygote with fluctuated neurological symptoms--a case report].
Matsumuro K; Kuriyama M; Yoshida Y; Okatsu Y; Osame M
Rinsho Shinkeigaku; 1991 Aug; 31(8):872-4. PubMed ID: 1764863
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
19. [X-linked adrenoleukodystrophy--case reports of 4 patients in a family].
Dumić M; Ille J; Fumić K; Kacić-Milicić Z; Cvitanović M; Plavsić V; Spehar A; Janjanin N; Filipović-Grcić B
Lijec Vjesn; 2002; 124(8-9):258-62. PubMed ID: 12587436
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
